Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

869.58
-43.1800-4.73%
Post-market: 867.75-1.8300-0.21%19:59 EST
Volume:4.82M
Turnover:4.22B
Market Cap:824.51B
PE:74.26
High:908.00
Open:905.39
Low:861.39
Close:912.76
Loading ...

Lilly: at New US Sites, Expect to Create Over 3,000 Jobs for Highly Skilled Workers & Nearly 10,000 Construction Jobs

THOMSON REUTERS
·
26 Feb

Lilly: Expects to Announce Four New Manufacturing Sites in US in 2025, Anticipate They Will Begin Making Medicines Within Five Yrs

THOMSON REUTERS
·
26 Feb

Lilly: Plans to Add About $27 Bln to US Capital Expansion Commitment, Bringing Total to More Than $50 Bln Since 2020

THOMSON REUTERS
·
26 Feb

Medicare spending on diabetes drugs surged over 5 years, US report shows

Reuters
·
26 Feb

Eli Lilly & Co’s Strategic Expansion and Growth Prospects Drive Buy Rating

TIPRANKS
·
26 Feb

Eli Lilly placed on ‘Positive Catalyst Watch’ at JPMorgan

TIPRANKS
·
26 Feb

Here's Why We Think Eli Lilly (NYSE:LLY) Might Deserve Your Attention Today

Simply Wall St.
·
26 Feb

Jim Cramer Says People Are Taking Up Eli Lilly and Company (LLY)

Insider Monkey
·
26 Feb

Post-Bell|Nasdaq Falls 1.4%; Li Auto up 13%; Alibaba up 4%; Nvidia, Palantir Down 3%; Coinbase Falls 6%; Tempus AI Drops 15%

Tiger Newspress
·
26 Feb

Eli Lilly Expands Zepbound Vial Dose Options, Cuts Weight-Loss Drug's Prices for Self-Pay Patients

MT Newswires
·
26 Feb

Hims & Hers tumbles 27% as investors fear uncertainty without compounded weight-loss drugs

Yahoo Finance
·
26 Feb

Top Midday Stories: Home Depot Shares Rise on Earnings Beat; Eli Lilly Launches Higher Single-Dose Vials of Zepbound at Lower Cost

MT Newswires Live
·
26 Feb

Why Eli Lilly Stock Popped Today

Motley Fool
·
26 Feb

Why Hims & Hers (HIMS) Stock Is Tumbling

Insider Monkey
·
26 Feb

Eli Lilly cuts price of weight-loss drug Zepbound as competition heats up

Dow Jones
·
25 Feb

Eli Lilly (LLY) Lowers Prices for Weight Loss Drug Zepbound

TIPRANKS
·
25 Feb